A multicolor fluorescence in situ hybridization assay: A monitoring tool in the surveillance of patients with a history of non-muscle-invasive urothelial cell carcinoma: A prospective study (Q84475759)

From Wikidata

Jump to navigation Jump to search

scientific article published on 29 June 2011

Language	Label	Description	Also known as
English	A multicolor fluorescence in situ hybridization assay: A monitoring tool in the surveillance of patients with a history of non-muscle-invasive urothelial cell carcinoma: A prospective study	scientific article published on 29 June 2011

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21717592%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

A multicolor fluorescence in situ hybridization assay: A monitoring tool in the surveillance of patients with a history of non-muscle-invasive urothelial cell carcinoma: A prospective study (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21717592%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

author name string

Ana B Galván

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21717592%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Marta Salido

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21717592%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Blanca Espinet

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21717592%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

José Placer

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21717592%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Lara Pijuan

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21717592%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Núria Juanpere

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21717592%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Josep Lloreta

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21717592%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Francesc Solé

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21717592%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Antoni Gelabert-Mas

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21717592%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

publication date

29 June 2011

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21717592%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Cancer Cytopathology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21717592%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

119

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21717592%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21717592%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

395-403

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21717592%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Bladder cancer: epidemiology, staging and grading, and diagnosis.

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.20168

7 January 2021

based on heuristic

inferred from DOI database lookup

EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.20168

7 January 2021

based on heuristic

inferred from DOI database lookup

The role of hexaminolevulinate fluorescence cystoscopy in bladder cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.20168

7 January 2021

based on heuristic

inferred from DOI database lookup

Flourescence cystoscopy--how to do it.

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.20168

7 January 2021

based on heuristic

inferred from DOI database lookup

Bladder cancer biomarkers and their role in surveillance and screening

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.20168

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical utility of a multiprobe FISH assay in voided urine specimens for the detection of bladder cancer and its recurrences, compared with urinary cytology

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.20168

7 January 2021

based on heuristic

inferred from DOI database lookup

The UroVysion fluorescence in situ hybridization assay is an effective tool for monitoring recurrence of bladder cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.20168

7 January 2021

based on heuristic

inferred from DOI database lookup

Fluorescence in situ hybridization for detecting transitional cell carcinoma: implications for clinical practice

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.20168

7 January 2021

based on heuristic

inferred from DOI database lookup

Multi-target fluorescence in situ hybridization in bladder washings for prediction of recurrent bladder cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.20168

7 January 2021

based on heuristic

inferred from DOI database lookup

Combined morphologic and fluorescence in situ hybridization analysis of voided urine samples for the detection and follow-up of bladder cancer in patients with benign urine cytology

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.20168

7 January 2021

based on heuristic

inferred from DOI database lookup

Monitoring intravesical therapy for superficial bladder cancer using fluorescence in situ hybridization.

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.20168

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical utility of fluorescent in situ hybridization for the surveillance of bladder cancer patients treated with bacillus Calmette-Guérin therapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.20168

7 January 2021

based on heuristic

inferred from DOI database lookup

The prognostic value of cytology and fluorescence in situ hybridization in the follow-up of nonmuscle-invasive bladder cancer after intravesical Bacillus Calmette-Guérin therapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.20168

7 January 2021

based on heuristic

inferred from DOI database lookup

A comparison of cytology and fluorescence in situ hybridization for the detection of urothelial carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.20168

7 January 2021

based on heuristic

inferred from DOI database lookup

The predictive value of multi-targeted fluorescent in-situ hybridization in patients with history of bladder cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.20168

7 January 2021

based on heuristic

inferred from DOI database lookup

UroVysion FISH test for detecting urothelial cancers: meta-analysis of diagnostic accuracy and comparison with urinary cytology testing

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.20168

7 January 2021

based on heuristic

inferred from DOI database lookup

The development of a multitarget, multicolor fluorescence in situ hybridization assay for the detection of urothelial carcinoma in urine

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.20168

7 January 2021

based on heuristic

inferred from DOI database lookup

Combined analysis of morphology and fluorescence in situ hybridization significantly increases accuracy of bladder cancer detection in voided urine samples

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.20168

7 January 2021

based on heuristic

inferred from DOI database lookup

Fluorescence in situ hybridization for detecting urothelial carcinoma: a clinicopathologic study

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.20168

7 January 2021

based on heuristic

inferred from DOI database lookup

The value of the UroVysion assay for surveillance of non-muscle-invasive bladder cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.20168

7 January 2021

based on heuristic

inferred from DOI database lookup

A multicolour fluorescence in situ hybridization test predicts recurrence in patients with high-risk superficial bladder tumours undergoing intravesical therapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.20168

7 January 2021

based on heuristic

inferred from DOI database lookup

Reflex UroVysion testing of bladder cancer surveillance patients with equivocal or negative urine cytology: a prospective study with focus on the natural history of anticipatory positive findings

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.20168

7 January 2021

based on heuristic

inferred from DOI database lookup

Reflex UroVysion testing in suspicious urine cytology cases

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.20168

7 January 2021

based on heuristic

inferred from DOI database lookup

A review on the current state of urine cytology emphasizing the role of fluorescence in situ hybridization as an adjunct to diagnosis

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.20168

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/CNCY.20168

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21717592%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21717592%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q84475759&oldid=1425394139"